Publication: Epidemiology and outcomes of dengue in kidney transplant recipients: A 20-year retrospective analysis and comparative literature review
Issued Date
2019-01-01
Resource Type
ISSN
13990012
09020063
09020063
Other identifier(s)
2-s2.0-85059080010
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Transplantation. Vol.33, No.1 (2019)
Suggested Citation
Subencha Pinsai, Sasisopin Kiertiburanakul, Siriorn P. Watcharananan, Surasak Kantachuvessiri, Sarinya Boongird, Jackrapong Bruminhent Epidemiology and outcomes of dengue in kidney transplant recipients: A 20-year retrospective analysis and comparative literature review. Clinical Transplantation. Vol.33, No.1 (2019). doi:10.1111/ctr.13458 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/52285
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Epidemiology and outcomes of dengue in kidney transplant recipients: A 20-year retrospective analysis and comparative literature review
Abstract
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background: Kidney transplant (KT) recipients in dengue-endemic areas are at risk of exposure. We investigated the epidemiology and outcomes from dengue in KT recipients at our transplant center and conducted a literature review. Materials and methods: We conducted a 20-year retrospective study of KT recipients who were diagnosed with laboratory-confirmed dengue from January 1997 to September 2017 according to the 2009 World Health Organization (WHO) classification. We analyzed clinical characteristics and treatment outcomes. Results: There were 13 (0.7%) dengue cases among 1917 KT recipients with a median age of 39 years (interquartile ranges [IQR], 22-46); 54% were males. Cases occurred with a median onset of 24 months (IQR, 6-122) after KT. Dengue was diagnosed via dengue NS1 antigen (85%), IgM antibodies (38.5%), or RT-PCR (15.4%). Patients were classified as having dengue without warning sign (30.8%), with warning sign (53.8%), or severe dengue (15.4%). All patients resolved without complications, except one had hemophagocytic lymphohistiocytosis. Ten (76.9%) patients experienced eGFR reduction with a median of 13.7 mL/min/1.73 m 2 (IQR, 8.3-20.5); eight (80%) had a full allograft function recovery. Conclusions: Dengue in KT recipients in endemic areas is uncommon. Although a transient decline in allograft function can occur, the overall clinical and allograft outcomes seem to be favorable.